Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA (arimoclomol) for Treatment of Niemann-Pick Disease Type C
November 21, 2024 16:51 ET | Source: Zevra Therapeutics MIPLYFFA, the first…
November 21, 2024 16:51 ET | Source: Zevra Therapeutics MIPLYFFA, the first…
Sign in to your account